We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

17 hedge funds and large institutions have $5.25M invested in Anixa Biosciences in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

18% more capital invested

Capital invested by funds: $4.45M → $5.25M (+$802K)

6% more funds holding

Funds holding: 16 → 17 (+1)

0.39% more ownership

Funds ownership: 6.1% → 6.5% (+0.39%)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$118K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$115K
3
UBS Group
UBS Group
Switzerland
+$114K
4
BlackRock
BlackRock
New York
+$26.4K
5
Bank of America
Bank of America
North Carolina
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$27K
2
Northern Trust
Northern Trust
Illinois
-$12.6K
3
Morgan Stanley
Morgan Stanley
New York
-$5.11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.68M +$115K +27,400 +4%
UBS Group
2
UBS Group
Switzerland
$1.04M +$114K +27,300 +12%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$409K – – –
BlackRock
4
BlackRock
New York
$344K +$26.4K +6,315 +8%
Northern Trust
5
Northern Trust
Illinois
$224K -$12.6K -3,000 -5%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$159K – – –
JP Morgan Chase
7
JP Morgan Chase
New York
$147K +$118K +28,280 +335%
SBH
8
Segall Bryant & Hamill
Illinois
$70K – – –
Morgan Stanley
9
Morgan Stanley
New York
$53K -$5.11K -1,220 -8%
RJA
10
Raymond James & Associates
Florida
$40K – – –
Wells Fargo
11
Wells Fargo
California
$33K – – –
Bank of America
12
Bank of America
North Carolina
$33K +$17.9K +4,272 +102%
Victory Capital Management
13
Victory Capital Management
Texas
$14K +$14.8K +3,534 New
TRCT
14
Tower Research Capital (TRC)
New York
$4K +$2.92K +698 +334%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$1K +$1.54K +369 New
Deutsche Bank
16
Deutsche Bank
Germany
– -$27K -7,711 Closed

ANIX Hedge Fund Activity: Q3 2019 in Review

17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2019, worth a combined $5.25M — up 18% from $4.45M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ANIX positions and 1 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $118K. The largest seller was Deutsche Bank, exiting entirely with an estimated $27K sold.

  • 17 institutional investors held Anixa Biosciences (ANIX) as of Q3 2019, up from 16 in Q2 2019.
  • Funds reported $5.25M of Anixa Biosciences stock for Q3 2019, up 18% quarter-over-quarter.
  • 2 funds opened new Anixa Biosciences positions in Q3 2019 and 1 closed out, a net change of +1 holder.
  • The largest Anixa Biosciences buyer in Q3 2019 was JP Morgan Chase, an estimated $118K added.
  • The largest Anixa Biosciences seller in Q3 2019 was Deutsche Bank, an estimated $27K sold.

Based on aggregated 13F filings for Q3 2019.